Iconic news
Icon Oncology and Avisena Specialist Hospital 2 expand access to advanced cancer care in Klang Valley
Icon Oncology and Avisena Specialist Hospital 2 Expand Access to Advanced Cancer Care in Klang Valley
New centre to provide comprehensive cancer services closer to home, including a dedicated programme supporting women affected by cancer.
KUALA LUMPUR, Wednesday, 2 September 2026 – Icon Sunsuria Sdn Bhd and Avisena Healthcare Sdn Bhd have signed an Operating Agreement to establish Icon Oncology at Avisena Specialist Hospital 2 (ASH2) in Klang Valley. The partnership brings together Icon Oncology’s specialist cancer care expertise with Avisena Healthcare’s established hospital capabilities and strong foundation in women’s health, creating a platform to deliver high-quality, multidisciplinary oncology care for patients.
The centre will serve the broader community and has been designed with a deliberate focus on women’s cancers, targeting some of the most prevalent malignancies affecting Malaysian women, including breast cancer, gynaecological cancer, colorectal cancer, and lung cancer, as reported by the Malaysia National Cancer Registry.
Specialist oncology care will be delivered within an integrated healthcare environment that brings together multidisciplinary expertise across oncology and women's health, enabling coordinated, personalised treatment at every stage of the patient journey. From diagnosis and active treatment through to follow-up and survivorship, the centre will place strong emphasis on clinical excellence, continuity of care, and a supportive patient experience.
The Operating Agreement was signed by Elina Nadia Omar, Group Chief Executive Officer of Avisena Healthcare, and Serena Wee, Chief Executive Officer of Icon ASEAN, and witnessed by Tan Sri Datuk Ter Leong Yap, Founder and Executive Chairman of Sunsuria Berhad, and Dato' Dr Omar Abd Hamid, Founder and Deputy Chairman of Avisena Healthcare.
Tan Sri Datuk Ter Leong Yap said cancer is a growing health challenge for women in Malaysia.
Through this partnership, we are investing in specialist cancer care where it is needed most while building on Avisena's strong reputation in women's health. Together with Icon Oncology Malaysia, we aim to deliver meaningful benefits for patients and their families across the Klang Valley.
The partnership marks a significant milestone in expanding access to specialist oncology services in one of Malaysia's most populous regions.
Serena Wee, Chief Executive Officer of Icon ASEAN, said the collaboration would provide a more seamless and integrated experience for patients.
At Icon, our purpose is to bring the best possible cancer care to more people, closer to home. This partnership combines Icon Oncology’s specialist expertise with Avisena’s trusted healthcare network to create a more connected and supportive experience for patients in Klang Valley. Importantly, it will strengthen access to multidisciplinary care for women affected by cancer, while supporting our broader commitment to advancing high-quality cancer care across Malaysia and ASEAN.
Elina Nadia Omar, Group Chief Executive Officer of Avisena Healthcare, said the partnership builds on Avisena's longstanding commitment to women's health.
Women's health has always been foundational to Avisena's clinical mission. By integrating specialist oncology services into our broader healthcare ecosystem, we strengthen our ability to deliver more coordinated care, greater patient convenience, and improved continuity across the entire treatment pathway. This integration is especially vital for cancers that disproportionately affect women, where timely, multidisciplinary intervention can make a meaningful difference in clinical outcomes and quality of life
The new centre is slated to start operations from September 2026.
We're here for you
If you have a question about becoming a patient at one of our centres or accessing our treatment services, we are here to help. We know that navigating a cancer diagnosis can be overwhelming, and can help you understand the process and what steps to take next.
